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Abstract
The Brown-Vialetto-Van Laere syndrome (BVVL) is a rare neurological disorder characterized by
progressive pontobulbar palsy associated with sensorineural deafness. Fifty-eight cases have been
reported in just over 100 years. The female to male ratio is approximately 3:1. The age of onset of
the initial symptom varies from infancy to the third decade. The syndrome most frequently
presents with sensorineural deafness, which is usually progressive and severe. Lower cranial nerve
involvement and lower and upper motor neuron limb signs are common neurological features.
Other features include respiratory compromise (the most frequent non-neurological finding), limb
weakness, slurring of speech, facial weakness, and neck and shoulder weakness. Optic atrophy,
retinitis pigmentosa, macular hyperpigmentation, autonomic dysfunction, epilepsy may occur. The
etiopathogenesis of the condition remains elusive. Approximately 50% of cases are familial, of which
autosomal recessive is suggested. The remaining cases are sporadic. The diagnosis is usually based
on the clinical presentation. Investigations (neurophysiological studies, magnetic resonance imaging
of the brain, muscle biopsy, cerebrospinal fluid examination) are done to exclude other causes or
to confirm the clinical findings. The differential diagnoses include the Fazio-Londe syndrome,
amyotrophic lateral sclerosis, Nathalie syndrome, Boltshauser syndrome and Madras motor
neuron disease. Treatment with steroids or intravenous immunoglobulin may result in temporary
stabilization of the syndrome. However, the mainstays of management are supportive and
symptomatic treatment, in particular assisted ventilation and maintenance of nutrition via
gastrostomy. The clinical course of BVVL is variable and includes gradual deterioration (almost half
of cases), gradual deterioration with stable periods in between (a third of cases) and deterioration
with abrupt periods of worsening (just under a fifth of cases). After the initial presentation, one
third of patients survive for ten years or longer.
Definition
The Brown-Vialetto-Van Laere syndrome (BVVL) is a rare
neurological disorder of unknown etiology, characterized
by progressive pontobulbar palsy associated with sen-
sorineural deafness. It was first described by Brown in
1894 [1], and later by Vialetto and Van Laere in 1936 [2]
and 1966 [3] respectively.
Epidemiology
Fifty-eight cases of BVVL have been reported in just over a
century (Additional file 1). Around half of all cases are
sporadic [4]. The majority of familial cases demonstrate
autosomal recessive inheritance, although autosomal
dominant [5,6] or X-linked inheritance [5] has been sug-
gested in a few families. The female to male ratio is
approximately 3:1 in reported cases. This may be the
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result of reporting bias as males tend to be more severely
affected and therefore die earlier in life [5-10].
Clinical description
It is difficult to map out accurately the clinical course of
BVVL as most case reports do not give a detailed account
of the development of symptoms and signs. However, in
the vast majority of cases the first symptom is sen-
sorineural deafness, which is usually progressive and
severe. The time between the onset of deafness and the
development of other symptoms has been reported to be
shorter in males (mean of approximately five years) than
in females (mean of almost 11 years) [11]. Very rarely,
affected cases do not appear to develop deafness, presum-
ably because these individuals die before the hearing
impairment develops [9]. Other initial presenting features
include limb weakness [12-15], respiratory compromise
[8,9], slurring of speech [16], facial weakness [9], and
neck and shoulder weakness [17]. The age of onset of the
initial symptom varies from infancy [2] to the third dec-
ade [18,19]. In a few cases, an intercurrent event, such as
an infection, appears to have precipitated the initial symp-
tom or worsened an existing symptom [2,7,8,12,20,21].
In BVVL, the lower cranial nerves VII to XII are commonly
affected, while abnormalities of cranial nerves II to VI
occur much less frequently. Cerebellar ataxia was reported
in one case [22]. Lower motor neuron (LMN) signs are
common in the limbs. Upper motor neuron (UMN)
involvement, for example brisk reflexes, clonus and exten-
sor plantar responses, is less frequent [5-11,13,14,19-26].
Sensation is rarely affected, with only one reported case of
subjective blunting of pinprick sensation below the knees
[16].
Several other neurological features have been seen in
patients with BVVL. Abnormalities of the fundi that have
been reported include optic atrophy [5,13,20,21,27],
retinitis pigmentosa [22] and macular hyperpigmentation
[25]. Autonomic dysfunction [2,13,28,29], epilepsy
[2,18], mental retardation [1,2,25], reduced horizontal
eye movements [6] and tremor [9,25] have also been asso-
ciated with BVVL.
Of the non-neurological features, respiratory compromise
is the most common in BVVL [4-13,15,17,19-21,24,27-
33]. Other non-neurological features that have been
reported include auditory hallucinations [2], behavioral
changes [27], color blindness [20], diabetes insipidus [1],
delayed puberty and hypogonadism [16], dysmorphic
features [25], gynecomastia [16] and hypertension
[11,33]. In some cases, no other associated non-neurolog-
ical features were reported [34-38].
Etiopathogenesis
The etiopathogenesis of BVVL remains elusive. Two
patients with BVVL have been screened for the mutations
associated with common forms of spinal muscular atro-
phy (SMA), the survival motor neuron gene (SMA) and
neuronal apoptosis inhibitory protein gene (NAIP), but
these proved negative (4,39). There are no other pub-
lished studies on the investigation of the genetic or molec-
ular pathogenesis of BVVL.
Diagnosis
The diagnosis of BVVL is based on the clinical description
of the syndrome, as there is no confirmatory test for the
condition. The major features of BVVL are the presence of
sensorineural deafness, involvement of lower cranial
nerves VII to XII and the presence of LMN, and to a lesser
extent UMN, signs in the limbs. However, except for the
sensorineural deafness, the presence of the other features
can be variable. Respiratory compromise is the most com-
mon non-neurological feature in BVVL. The other neuro-
logical and non-neurological features seen in patients
with BVVL described in the section 'Clinical description'
are seen much less frequently.
Investigations are usually done to exclude other causes or
confirm the clinical signs of the patients. Neurophysiolog-
ical studies show changes consistent with chronic
[5,7,9,11-14,16,21,22,25,28,33] or active [6-
8,15,19,20,24,26,27,29,33] denervation in muscles.
Motor nerve conduction velocities are usually normal.
Sensory action potentials are rarely reduced [4,6,7]. Visual
evoked potentials performed in 15 cases showed normal
values in seven patients [9,14,25,28,32,33] and pro-
longed latencies in the rest [5,7,10,12,13,15,19,21,29].
Brainstem auditory evoked potentials were abnormal
when performed in 17 cases [4,5,8,10,12-
15,21,25,27,32,33]. When carried out, audiometry uni-
versally showed sensorineural deafness. Electroencepha-
logram may show an excess of theta activity or slow waves
[5,20,23,30]. Electrocardiogram showed incomplete right
bundle branch block in one case [4]. Polysomnography
demonstrated predominantly central sleep apnea with
minimal obstructive sleep apnea in one case [32].
Magnetic resonance imaging of the brain may show atro-
phy of the brainstem [21,25,27] and cerebellum [21,25],
or hyperintensity in the brainstem nuclei [10,27], cerebel-
lar peduncles [29], internal capsule [29] or subcortical
white matter [29].
Muscle biopsy was carried out on eight patients. In four
cases it showed normal muscle histology [6,9,11,27], in
one case it showed increased lipid content and myopathic
changes (unspecified) [29], while in the remaining cases
there was evidence of grouped atrophic fibres suggestingOrphanet Journal of Rare Diseases 2008, 3:9 http://www.ojrd.com/content/3/1/9
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denervation [5,7,12,14,20,22,25,28]. Sural nerve biopsies
were undertaken in two patients, with one showing
axonal depletion [22], while the other was normal [20].
Cerebrospinal fluid examination in BVVL may show
mildly elevated protein content [5,12,13,30,33].
There are few pathological descriptions of BVVL available
due to the rarity of the condition [7,12,13,20,30]. There is
usually neuronal injury and loss in the III, V, VI and lower
cranial nerve nuclei (VII – XII). However, studies in a two-
year old boy [7] and a 10-year old girl [30], revealed nor-
mal cranial nerve nuclei III, V and VI. Other neuropatho-
logical findings include depletion of spinal anterior horn
cells [12,13,20,30], degeneration of spinocerebellar
[13,20,30] and pyramidal [13,20] tracts, degeneration of
cerebellar Purkinje cells [20], and abnormalities in the
substantia nigra [12,13], locus coeruleus [12,20], olives
[12,13], cuneate nucleus [12], gracile nucleus [12,20],
ambiguous nucleus [7,12,20], dorsal nucleus of Clarke
[12,20,30], fastigial nucleus [20], lateral lemnisci [12,20],
medial longitudinal fasciculus [12], trapezoid body
[12,13], optic pathways [12] and solitary tract [12,20].
Differential diagnosis
There are several conditions that closely resemble BVVL
and that should always be considered in the differential
diagnosis. It would be unrealistic to expect to make a diag-
nosis of BVVL in a patient who initially presents with just
sensorineural deafness. The development of other cranial
nerve and limb involvement in conjunction with sen-
sorineural deafness is likely to be needed to secure the
diagnosis with any degree of confidence. Figure 1 provides
a diagnostic algorithm to aid in the diagnosis of this rare
disorder.
Perhaps the most closely related condition is the progres-
sive bulbar paralysis of Fazio-Londe [40], where the only
distinguishing feature from BVVL is the absence of deaf-
ness. In fact, in the case reported by Voudris and col-
leagues [8], deafness was not clinically recognized and
was only picked up by brainstem auditory evoked poten-
tial testing. In addition, in two of the four cases by Dipti
and colleagues [9] who presented early in life, deafness
was not thought to be present, possibly implying that the
patients died before the deafness had developed.
Amyotrophic lateral sclerosis (ALS) is another alternative
diagnosis. However, it does not usually present at a young
age and sensorineural deafness is not a feature of this con-
dition.
Another differential of BVVL is the Nathalie syndrome,
which is a rare condition characterized by deafness in con-
Diagnostic algorithm for BVVL Figure 1
Diagnostic algorithm for BVVL.
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junction with spinal muscular atrophy, cataract, cardiac
conduction defects and hypogonadism [41]. Interestingly,
one reported case of BVVL had a partial right bundle
branch block on electrocardiography [4] and another had
hypogonadism [16].
The Boltshauser syndrome, which is characterized by dis-
tal muscular atrophy with vocal cord paralysis and sen-
sorineural hearing loss, is also very similar to BVVL [42].
However, in the former, the brainstem signs are restricted
to vocal cord paralysis and the inheritance is likely to be
autosomal dominant. Autosomal dominant inheritance is
very uncommon in BVVL, with only two possible families
reported [5,6].
The Madras motor neuron disease (MMND) is another
condition closely related to BVVL [43]. MMND is charac-
terized by wasting and weakness of limb muscles, sen-
sorineural deafness and multiple cranial nerve palsies
usually affecting cranial nerves VII, IX and XII. Dysfunc-
tion of cranial nerves III and VI has not been reported in
MMND [44]. Only about 15% of cases of MMND are
familial [44], compared to 50% in BVVL [4].
Management and treatment
There is no specific treatment for BVVL. Steroids and
immunoglobulins have been tried in several cases. Tem-
porary stabilization was reported two patients. In the first,
steroids stabilized the condition temporarily for at least
eight months [7]. Stabilization of the condition for a year
was seen in another patient who received intravenous
immunoglobulin [11]. However, two other patients who
received intravenous immunoglobulin failed to show any
improvement [28,32].
Supportive care and symptomatic treatment are the main-
stays of management for BVVL. In a rare condition like
BVVL, evidence for the effectiveness of these measures is
anecdotal as it would be impossible to carry out rand-
omized controlled trials with the small numbers of
patients available. However, the benefit from experience
of using these methods in other similar conditions, in par-
ticular ALS, can be extrapolated for BVVL: for example, in
ALS assisted ventilation and maintenance of nutrition
have been proven to improve survival [45].
In BVVL, assisted ventilation has been shown to be useful
when respiratory compromise is a major feature. Long-
term nocturnal ventilatory support was beneficial in some
cases [5,6,9,15,19]. Tracheostomy and full ventilatory
support was helpful in other cases [8-
10,20,24,28,29,31,32]. In patients where dysphagia is a
major problem, gastrostomy can alleviate its symptoms
and maintain good nutritional status [6,8-10,13,28].
Prognosis
The clinical course of BVVL is variable in the 58 cases
reported in the literature (Additional file 1). In 26 cases
(45%), patients had gradual deterioration (GD), while in
19 cases (33%), there was gradual deterioration with sta-
ble periods in between (GDS). Ten patients (17%) had
deterioration with abrupt periods of worsening (DW).
The clinical course was not known in three cases (5%). At
least 21 patients (36%) survived for 10 or more years after
the initial symptom. Twenty three patients (40%) sur-
vived for five or less years after the onset of the first symp-
tom.
Unresolved questions
The key unanswered question in BVVL is the molecular
pathogenesis of the condition. Although the syndrome is
very rare, advances in molecular biotechnology offer hope
that the underlying pathogenesis of the disease will be
unravelled in the near future.
It is likely that we still do not know the full clinical spec-
trum of BVVL. Thus, it is important that as more and more
cases of BVVL are recognized, these cases continue to be
reported in the literature to enhance our knowledge and
understanding of this rare progressive neurological disor-
der. This will enable affected individuals and families to
be provided with a better idea of the clinical course, prog-
nosis and management of this debilitating condition.
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